Alexandra de Pokomandy

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Prevalence, Clearance, and Incidence of Anal Human Papillomavirus Infection in HIV‐Infected Men: The HIPVIRG Cohort Study

Alexandra de Pokomandy, Danielle Rouleau, George Ghattas et al. · The Journal of Infectious Diseases · 2009 · 194 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation

Claudie Laprise, Alexandra de Pokomandy, J.-G. Baril et al. · Clinical Infectious Diseases · 2013 · 178 citations

Life Sciences, Infectious Diseases, Molecular Virology +13

HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIV

Alexandra de Pokomandy, Danielle Rouleau, Georges Ghattas et al. · Clinical Infectious Diseases · 2011 · 158 citations

Medicine, Infectious Diseases, Pathology +16

HIV-related stigma, racial discrimination, and gender discrimination: Pathways to physical and mental health-related quality of life among a national cohort of women living with HIV

Carmen H. Logie, Ying Wang, Ashley Lacombe‐Duncan et al. · Preventive Medicine · 2017 · 140 citations

Social Sciences, Gender Studies, Discrimination +11